Compare StocksABBV vs VST

AbbVie Inc. (ABBV) vs Vistra Corp. (VST): Which Is the Better Buy in 2026?

As of 2026-06-19, ABBV is overvalued at $216, with a DCF intrinsic value of $160 and a margin of safety of -35%. VST is fairly valued at $164, with an intrinsic value of $170 and a margin of safety of 4%. Of the two, VST has the wider margin of safety.

ABBV
AbbVie Inc.
$216.49
VS
VST
Vistra Corp.
$163.75

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
VST
  • Share count has been reduced by 13% over the past 4 years through buybacks, increasing each share's claim on earnings.
  • Each dollar of retained earnings has created $4.93 of earning power — management is an exceptional capital allocator.
  • PEG ratio of 0.47 suggests the stock is undervalued relative to its growth rate — paying less than 1x for each unit of earnings growth.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 105.6x is 69% above the historical average of 62.3x — the stock trades at a premium to its own history.
VST
  • FCF yield of 2.4% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • High leverage (3.43x net debt/equity) combined with thin interest coverage (-1.0x) poses financial risk.
  • Altman Z-Score of 1.42 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.

Key Valuation Metrics

Learn more →
ABBV
VST
Valuation
$20.81B
Free Cash Flow
$1.32B
5.44%
FCF Yield
2.39%
105.60
Trailing P/E
27.38
13.32
Forward P/E
14.90
Quality & Moat
21.89%
ROIC
15.99%
N/A
ROE
42.90%
72.03%
Gross Margin
38.64%
0.61
PEG Ratio
0.47
Balance Sheet Safety
N/A
Net Debt / Equity
3.43
N/A
Interest Coverage
N/A
2.12
Net Debt / EBITDA
2.84
3.11%
Dividend Yield
0.57%
ABBV: 7Ties: 1VST: 2
ABBVVST

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

VST

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
VST
$12.44
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$3.66B
Δ Market Cap
+$45.50B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
35.3% Overvalued
Price is 35.3% above estimated fair value
Current Price: $216.49
Fair Value: $160.05
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
VST
3.9% Margin of Safety
Price is 3.9% below estimated fair value
Current Price: $163.75
Fair Value: $170.34
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $216?

+17.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +17.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.7%, reflecting heavy growth investment.

VST

What growth rate is the market pricing in at $164?

+23.9%
Market-Implied Owner Earnings Growth
Standard FCF implies +21.9%

The market implies +23.9% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +21.9%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
VST
44/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving margin stability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
VST
-2.54
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,106
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
VST
Insiders 0.8%Institutions 91.2%Retail & Other 8.1%
No. of Institutional Holders1,762
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
VST
0
Buys (3M)
0
Buys (12M)
PITESA JOHN WILLIAM
Director
$190,125
@ $126.75 · 2025-03-12
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
VST
2
Sells (3M)
27
Sells (12M)
Total value (12M): $187.98M
MONTEMAYOR MARGARET M.
Officer
$736,000
@ $160.00 · 2026-06-02
MONTEMAYOR MARGARET M.
Officer
$824,800
@ $164.96 · 2026-05-27
MOORE STEPHANIE ZAPATA
General Counsel
$1.60M
@ $160.31 · 2026-03-09
BURKE JAMES A.
Chief Executive Officer
$3.61M
@ $162.05 · 2025-12-11
BURKE JAMES A.
Chief Executive Officer
$3.61M
@ $162.05 · 2025-12-11
MOORE STEPHANIE ZAPATA
General Counsel
$1.42M
@ $173.35 · 2025-11-24
HUDSON SCOTT A
Officer
$9.46M
@ $168.86 · 2025-11-14
KIRBY CARRIE LEE
Officer
$10.18M
@ $174.75 · 2025-11-14
BURKE JAMES A.
Chief Executive Officer
$4.09M
@ $186.53 · 2025-11-11
BURKE JAMES A.
Chief Executive Officer
$1.85M
@ $192.30 · 2025-10-29
BURKE JAMES A.
Chief Executive Officer
$4.17M
@ $203.64 · 2025-10-27
BURKE JAMES A.
Chief Executive Officer
$7.52M
@ $191.79 · 2025-10-24
BURKE JAMES A.
Chief Executive Officer
$4.08M
@ $188.75 · 2025-10-22
BURKE JAMES A.
Chief Executive Officer
$8.81M
@ $206.11 · 2025-10-20
BURKE JAMES A.
Chief Executive Officer
$9.07M
@ $212.28 · 2025-10-16
BURKE JAMES A.
Chief Executive Officer
$17.21M
@ $204.51 · 2025-10-14
BURKE JAMES A.
Chief Executive Officer
$8.38M
@ $204.62 · 2025-10-09
BURKE JAMES A.
Chief Executive Officer
$8.73M
@ $204.21 · 2025-10-07
BURKE JAMES A.
Chief Executive Officer
$8.74M
@ $204.44 · 2025-10-03
BURKE JAMES A.
Chief Executive Officer
$7.72M
@ $197.04 · 2025-10-01
BURKE JAMES A.
Chief Executive Officer
$8.62M
@ $201.56 · 2025-09-29
BURKE JAMES A.
Chief Executive Officer
$8.63M
@ $201.86 · 2025-09-25
BURKE JAMES A.
Chief Executive Officer
$8.99M
@ $210.52 · 2025-09-23
BURKE JAMES A.
Chief Executive Officer
$9.07M
@ $212.34 · 2025-09-19
BURKE JAMES A.
Chief Executive Officer
$9.11M
@ $213.17 · 2025-09-17
BURKE JAMES A.
Chief Executive Officer
$8.82M
@ $206.32 · 2025-09-15
BURKE JAMES A.
Chief Executive Officer
$12.93M
@ $206.26 · 2025-09-11
MOLDOVAN KRISTOPHER E.
Chief Financial Officer
$6.29M
@ $180.00 · 2025-06-17
SULT JOHN R
Director
$4.29M
@ $171.67 · 2025-06-06
HELM SCOTT BRADFORD
Director
$8.64M
@ $172.75 · 2025-06-05
MOLDOVAN KRISTOPHER E.
Chief Financial Officer
$7.20M
@ $160.00 · 2025-05-27
MOORE STEPHANIE ZAPATA
General Counsel
$5.65M
@ $161.44 · 2025-05-27
HUDSON SCOTT A
Officer
$8.79M
@ $157.00 · 2025-05-20
HELM SCOTT BRADFORD
Director
$3.14M
@ $156.80 · 2025-05-19
KIRBY CARRIE LEE
Officer
$16.95M
@ $156.98 · 2025-05-19
MOLDOVAN KRISTOPHER E.
Chief Financial Officer
$1.55M
@ $150.00 · 2025-05-13
MOLDOVAN KRISTOPHER E.
Chief Financial Officer
$6.95M
@ $140.00 · 2025-05-01
HELM SCOTT BRADFORD
Director
$2.80M
@ $139.77 · 2024-12-10
HUDSON SCOTT A
Officer
$18.88M
@ $164.16 · 2024-11-25
MUSCATO STEPHEN J
Officer
$33.41M
@ $161.34 · 2024-11-22
KIRBY CARRIE LEE
Officer
$13.79M
@ $162.28 · 2024-11-22
MOORE STEPHANIE ZAPATA
General Counsel
$6.18M
@ $161.94 · 2024-11-22
MOORE STEPHANIE ZAPATA
General Counsel
$2.79M
@ $80.37 · 2024-08-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
VST
FearGreed
😐Neutral(41/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
VST
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (41)
View ABBV Full AnalysisView VST Full Analysis

Frequently Asked Questions: ABBV vs VST

Is AbbVie Inc. or Vistra Corp. more undervalued in 2026?

Based on our discounted cash flow model, VST trades at a 3.9% margin of safety (intrinsic value $170 vs. price $164), compared to ABBV's -35.3% margin of safety (intrinsic $160 vs. $216).

Which stock has a wider economic moat, AbbVie Inc. or Vistra Corp.?

ABBV scores 82/100 (Wide moat), while VST scores 44/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Vistra Corp. in financial distress?

VST's Altman Z-Score of 1.4 places it in the Distress zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, AbbVie Inc. or Vistra Corp.?

AbbVie Inc. (ABBV) generates a 5.4% free cash flow yield, compared to Vistra Corp.'s 2.4%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, AbbVie Inc. or Vistra Corp.?

ABBV earns 21.9% ROIC versus VST's 16.0%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Vistra Corp.'s?

VST's dividend earns a safety score of 84/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). VST has raised its dividend for 3 consecutive years.